Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2023

Dec 19, 2023

32106_dirs_2023-12-19_4575a6db-5775-4341-8d8a-743e67a7c701.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-12-17

Reporting Person: Phillips Geraint (SVP, Global Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-17 Common Stock A 211 Acquired 59798 Direct

Footnotes

F1: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.